At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 22 enrolled
Drug / intervention
Metoprololdrug
Likely dose
Metoprolol 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
In Brief
A Phase 4 clinical trial evaluating Metoprolol for Hypertrophic Cardiomyopathy. Completed, enrolled 22 participants across 1 site.
Detailed Summary
In this trial, the investigators will assess the effect of metoprolol in patients with hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will evaluate the quality of life, exercise tolerance, echocardiographic parameters and laboratory marker of heart failure and myocardial injury.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertrophic Cardiomyopathy
CountriesCzechia
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartMar 2020
Primary CompletionFeb 2023
TodayJul 2026
First PostedOct 21, 2019
Enrollment StartMar 5, 2020
Primary CompletionFeb 23, 2023
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 6.7 years ago
Interventions
Metoprololdrug
metoprolol 50 mg daily for three months